Presentations from the 8th EBE annual regulatory conference on ATMPs – “Handling the ATMPs challenges to timely meet patient needs”

10 Dec 2019

“Handling the ATMPs challenges to timely meet patient needs”

The 8th annual regulatory conference organised by the European Biopharmaceutical Enterprises (EBE)

4 December 2019, Hotel Novotel Amsterdam City, Europaboulevard 10,
1083 AD Amsterdam, The Netherlands


The field of advanced therapy medicinal products (ATMPs) is rapidly growing and holds the promise to treat and potentially cure a broad range of diseases.

Given the unique and complex nature of the ATMPs, their development raises particular challenges in several areas such as manufacturing or clinical trial design.

EBE’s 2019 conference has discussed some innovative solutions proposed by ATMPs developers to address regulatory requirements in order to timely meet patient needs. 

Thank you for joining us on 4 December 2019 in Amsterdam!

The EBE Team


Session 1 – Enhancing AAV vectors manufacturing
Session 2 – Optimising clinical trial design for ATMPs development
Session 3 – ATMPs development for pediatric patient treatments
Session 4 – Towards an appropriate implementation of Hospital Exemptions
2019-12-10T13:31:13+00:00December 10, 2019|